| Product Name | MF | CAS | Details |
|---|
| Dabigatran Impurity P | C18H22N4O3 | 212322-56-0 | Details |
| Olmesartan Medoxomil Impurity6 | C9H11N3O | 144690-06-2 | Details |
| Dabigatran Impurity L | C32H38N8O4 | 1580491-16-2 | Details |
| Linezolid Impurity16 | C10H12FNO | 384344-17-6 | Details |
| Levocetirizine Impurity 3 | C19H23ClN2O | 109806-71-5 | Details |
| Olmesartan Medoxomil Impurity12 | C45H44N6O3 | 172875-59-1 | Details |
| Gefitinib Impurity 9 | C10H12N4 | 194423-17-1 | Details |
| Dabigatran etexilate impurity15 | C25H25N7O3 | 211914-51-1 | Details |
| Olmesartan Medoxomil Impurity3 | C33H26N4O | 154709-18-9 | Details |
| Olmesartan Medoxomil Impurity4 | C45H42N6O4 | 144690-53-9 | Details |
| LCZ696 impurities4 | C25H33NO4 | 149709-60-4 | Details |
| Troxagliptin impuritiesT | C18H21N5O2 | 850649-61-5 | Details |
| Gefitinib Impurity 4 | C15H21N3O6 | 861453-16-9 | Details |
| Clopidogrel Impurities7 | C16H16ClNO5S2 | 2173294-69-2 | Details |
| Erlotinib Impurity5 | C8H7N | 54060-30-9 | Details |
| Erlotinib O-Desmethyl Metabolite Isomer (M13) | C21H21N3O4 | 183320-29-8 | Details |
| Clopidogrel Impurities6 | C7H9NS | 28783-41-7 | Details |
| Afatinib Impurity13 | C7H5FN2O4 | 1194097-41-0 | Details |
| Dabigatran Impurity K | C33H39N7O5 | 211915-00-3 | Details |
| Afatinib ImpurityC | C24H25ClFN5O3 | 945553-91-3 | Details |
| Afatinib Impurity4 | C8H4FN3O3 | 162012-69-3 | Details |
| Sorafenib impurities12 | C21H17F3N4O3 | 1285533-84-7 | Details |
| Gefitinib Impurity 7 | C15H11ClFN3O2 | 184475-71-6 | Details |
| alogliptin impurities3 | C31H30N8O4 | 1268836-55-0 | Details |
| Dabigatran Impurity 17 | C29H31N5O5 | 1422495-93-9 | Details |
| Dabigatran etexilate impurity8 | C14H21N3O2 | 255706-13-9 | Details |
| Clopidogrel EP Impurity C Sulfate | C16H18ClNO6S2 | 120202-71-3 | Details |
| Clopidogrel Impurities9 | C16H18ClNO6S2 | 135046-48-9 | Details |
| Linezolid Impurity1 | C16H18FN3O4 | 1997296-64-6 | Details |
| Gefitinib Impurity 10 | C15H19N3O5 | 1006378-06-8 | Details |
| Linezolid Impurity 23 | C17H22FN3O4 | 216869-17-9 | Details |
| Olmesartan Medoxomil Impurity16 | C48H44N6O6 | 144690-92-6 | Details |
| Erlotinib O-Desmethyl Metabolite Isomer (M14) | C21H21N3O4 | 183321-86-0 | Details |
| Olmesartan Medoxomil Impurity18 | C45H42N6O2 | 157356-74-6 | Details |
| Dabigatran etexilate impurityE | C34H41N7O5 | 1610758-22-9 | Details |
| Dabigatran Impurity 24 | C20H22N4O3 | 1456889-80-7 | Details |
| Afatinib Impurity8 | C18H16ClFN4O2 | 314771-76-1 | Details |
| alogliptin impurities11 | C20H13ClN4O2 | 1618644-29-3 | Details |
| LCZ696 impurities518-12 | C22H23NO4 | 1639970-62-9 | Details |
| Sorafenib impurities9 | C21H15ClF3N3O4 | 573673-43-5 | Details |
| Sorafenib impurities1 | C15H8Cl2F6N2O | 370-50-3 | Details |
| Olmesartan Medoxomil Impurity2 | C43H40N6O3 | 761404-85-7 | Details |
| Gefitinib Impurity 8 | C15H20N2O3 | 675126-28-0 | Details |
| Azilsartan medoxomil impurity4 | C23H16N4O5 | 1442400-68-1 | Details |
| Erlotinib Impurity3 | C22H24ClN3O4 | 183319-69-9 | Details |
| Cetirizine EP Impurity A | C17H19ClN2 | 303-26-4 | Details |
| Troxagliptin impuritiesS | C18H21FN4O4 | 1917324-15-2 | Details |
| Dabigatran etexilate impurity13 | C34H40N6O6 | 1408238-40-3 | Details |
| Olmesartan Medoxomil Impurity15 | C48H42N6O5 | 1227626-51-8 | Details |
| Afatinib Impurity12 | C8H3ClFN3O2 | 162012-70-6 | Details |
| Dabigatran etexilate impurity12 | C27H28N6O4 | 1422435-41-3 | Details |
| Olmesartan Medoxomil Impurity17 | C44H40N6O3 | 2101308-74-9 | Details |
| alogliptin impurities5 | C18H23N5O3 | 1820685-30-0 | Details |
| Olmesartan Medoxomil EP Impurity D | C48H44N6O6 | 1020157-01-0 | Details |
| Sorafenib impurities8 | C20H14ClF3N4O3 | 284461-74-1 | Details |
| Azilsartan medoxomil Impurity D | C22H18N4O4 | 1821386-21-3 | Details |
| Linezolid Impurity 22 | C13H18ClFN2O2 | 1610690-08-8 | Details |
| Clopidogrel EP Impurity B | C16H16ClNO2S | 1396841-05-6 | Details |
| Linezolid Impurity12 | C28H33F2N5O6 | 2307625-63-2 | Details |
| N,O-Desethylene Linezolid | C14H18FN3O4 | 1219708-30-1 | Details |
| Sorafenib impurities11 | C21H16ClF3N4O4 | 583840-03-3 | Details |
| Troxagliptin impurities2 | C18H20FN5O2 | 1812193-01-3 | Details |
| Linezolid Impurity5 | C15H20N2O6S | 556801-09-3 | Details |
| Troxagliptin impuritiesI | C31H28F2N8O4 | 1917324-13-0 | Details |
| Dechlorocetirizine dihydrochloride | C21H26N2O3 | 83881-54-3 | Details |
| Afatinib ImpurityD | C24H25ClFN5O3 | 1680184-59-1 | Details |
| Troxagliptin impurities5 | C22H24FN5O5 | 2087874-92-6 | Details |
| Cetirizine USP Impurity B | C19H26Cl2N2O | 108983-83-1 | Details |
| Linezolid Impurity17 | C15H22FN3O3 | 333753-71-2 | Details |
| Linezolid Impurity 19 | C13H20FN3O2 | 1532560-87-4 | Details |
| alogliptin impurities10 | C12H8ClN3O2 | 865758-95-8 | Details |
| Linezolid Impurity 18 | C15H19FN2O6S | 174649-09-3 | Details |
| Sorafenib impurities2 | C21H16ClF3N4O3 | 1431697-81-2 | Details |
| Clopidogrel EP Impurity F HCl | C15H17Cl2NO2S | 141109-19-5 | Details |
| Oxcarbazepine EP Impurity K | C16H12N2O3 | 1346601-76-0 | Details |
| Linezolid Impurity10 | C18H19FN2O3 | 168828-81-7 | Details |
| Dabigatran Etexilate N-Oxide | C34H41N7O6 | 1381757-44-3 | Details |
| Azilsartan medoxomil Impurity M | C24H19N3O3 | 632322-61-3 | Details |
| alogliptin impurities14 | C10H20N2O2 | 309956-78-3 | Details |
| Sorafenib impurities12 | C27H23N5O6 | 2204442-52-2 | Details |
| Clopidogrel EP Impurity E(R) | C15H15ClN2OS | 444728-15-8 | Details |
| Olmesartan Medoxomil Impurity1 | C26H30N6O3 | 144689-23-6 | Details |
| Troxagliptin impurities3 | C21H13ClF2N4O2 | 1821400-07-0 | Details |
| Dabigatran etexilate impurity5 | C27H29N7O3.C7H8O3S | 872728-85-3 | Details |
| Dabigatran Impurity 20 | C19H20N4O3 | 1422435-40-2 | Details |
| Sorafenib impurities13 | C7H7ClN2O | 220000-87-3 | Details |
| Cetirizine EP Impurity E | C23H29ClN2O4 | 682323-77-9 | Details |
| Olmesartan Medoxomil Impurity9 | C8H8N4 | 51802-42-7 | Details |
| Linezolid Impurity9 | C18H20N2O3 | 348626-43-7 | Details |
| Levocetirizine Impurity 4 | C10H13Cl2NO2S | 58023-19-1 | Details |
| Oxcarbazepine EP Impurity G | C16H13N3O2 | 1219170-51-0 | Details |
| Dabigatran etexilate impurity7 | C19H20N4O4 | 1642853-67-5 | Details |
| Sorafenib impurities3 | C20H19N5O3 | 2004659-83-8 | Details |
| Gefitinib Impurity 1 | C11H9ClN2O3 | 230955-75-6 | Details |
| Azilsartan medoxomil Impurity A | C25H23N3O4 | 147404-76-0 | Details |
| Azilsartan medoxomil Impurity O | C25H22N2O5 | 1675221-59-6 | Details |
| LCZ696 impuritiesF | C23H29NO4 | 1012341-54-6 | Details |
| Azilsartan medoxomil impurity2 | C24H22N4O3 | 1442400-65-8 | Details |
| alogliptin impurities12 | C10H16N4O2 | 2276323-24-9 | Details |
| Levocetirizine Impurity 2 | C28H32ClN3O2 | 1150310-68-1 | Details |
| Product Total： Product Page： | ||||
| 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 | ||||